Axonal transport, also called axoplasmic transport or axoplasmic flow, is a cellular process responsible for movement of mitochondria, lipids, synaptic vesicles, proteins, and other organelles to and from a neurons cell body, through the cytoplasm of its axon called the axoplasm. Since some axons are on the order of meters long, neurons cannot rely on diffusion to carry products of the nucleus and organelles to the end of their axons. Axonal transport is also responsible for moving molecules destined for degradation from the axon back to the cell body, where they are broken down by lysosomes.
The vast majority of axonal proteins are synthesized in the neuronal cell body and transported along axons. Some mRNA translation has been demonstrated within axons. Axonal transport occurs throughout the life of a neuron and is essential to its growth and survival. Microtubules (made of tubulin) run along the length of the axon and provide the main cytoskeletal "tracks" for transportation. Kinesin and dynein are motor proteins that move cargoes in the anterograde (forwards from the soma to the axon tip) and retrograde (backwards to the soma (cell body)) directions, respectively. Motor proteins bind and transport several different cargoes including mitochondria, cytoskeletal polymers, autophagosomes, and synaptic vesicles containing neurotransmitters.
Axonal transport can be fast or slow, and anterograde (away from the cell body) or retrograde (conveys materials from axon to cell body).
Fast and slow transport
Vesicular cargoes move relatively fast (50–400 mm/day) whereas transport of soluble (cytosolic) and cytoskeletal proteins takes much longer (moving at less than 8 mm/day). The basic mechanism of fast axonal transport has been understood for decades but the mechanism of slow axonal transport is only recently becoming clear, as a result of advanced imaging techniques. Fluorescent labeling techniques (e.g. fluorescence microscopy) have enabled direct visualization of transport in living neurons. (See also: Anterograde tracing.)
Recent studies have revealed that the movement of cytoskeletal "slow" cargoes is actually rapid but unlike fast cargoes, they pause frequently, making the overall transit rate much slower. The mechanism is known as the "Stop and Go" model of slow axonal transport, and has been extensively validated for the transport of the cytoskeletal protein neurofilament. The movement of soluble (cytosolic) cargoes is more complex, but appears to have a similar basis where soluble proteins organize into multi-protein complexes that are then conveyed by transient interactions with more rapidly moving cargoes moving in fast axonal transport. An analogy is the difference in transport rates between local and express subway trains. Though both types of train travel at similar velocities between stations, the local train takes much longer to reach the end of the line because it stops at every station whereas the express makes only a few stops on the way.
The anterograde movement of individual cargoes (in transport vesicles) of both fast and slow components along the microtubule is mediated by kinesins. Several kinesins have been implicated in slow transport, though the mechanism for generating the "pauses" in the transit of slow component cargoes is still unknown.
There are two classes of slow anterograde transport: slow component a (SCa) that carries mainly microtubules and neurofilaments at 0.1-1 millimeters per day, and slow component b (SCb) that carries over 200 diverse proteins and actin at a rate of up to 6 millimeters per day. The slow component b, which also carries actin, are transported at a rate of 2-3 millimeters per day in retinal cell axons.
During reactivation from latency, the herpes simplex virus (HSV) enters its lytic cycle, and uses anterograde transport mechanisms to migrate from dorsal root ganglia neurons to the skin or mucosa that it subsequently affects.
A cargo-receptor for anterograde transport motors, the kinesins, has been identified as the amyloid precursor protein (APP), the parent protein that produces the senile plaques found in Alzheimer's disease. A 15-amino acid peptde in the cytoplasmic carboxyl terminus of APP binds with high affinity to conventional kinesin-1 and mediates transport of exogenous cargo in the giant axon of the squid.
Manganese, a contrast agent for T1-weighted MRI, travels by anterograde transport after stereotaxic injection into the brain of experimental animals and thereby reveals circuitry by whole brain MR imaging in living animals, as pioneered by Robia Pautler, Elaine Bearer and Russ Jacobs. Studies in kinesin-light chain-1 knocked out mice revealed that Mn2+ travels by kinesin-based transport in the optic nerve and in the brain. Transport in both hippocampal projections and in the optic nerve also depends on APP. Transport from hippocampus to forebrain is decreased in aging and destination is altered by the presence of Alzheimer's disease plaques.
Retrograde transport shuttles molecules/organelles away from axon termini toward the cell body. Retrograde axonal transport is mediated by cytoplasmic dynein, and is used for example to send chemical messages and endocytosis products headed to endolyosomes from the axon back to the cell. Operating at average in vivo speeds of approximately 2 μm/sec, fast retrograde transport can cover 10-20 centimeters per day.
Fast retrograde transport returns used synaptic vesicles and other materials to the soma and informs the soma of conditions at the axon terminals. Retrograde transport carries survival signals from the synapse back to the cell body, such as the TRK, the nerve growth factor receptor. Some pathogens exploit this process to invade the nervous system. They enter the distal tips on an axon and travel to the soma by retrograde transport. Examples include tetanus toxin and the herpes simplex, rabies, and polio viruses. In such infections, the delay between infection and the onset of symptoms corresponds to the time needed for the pathogens to reach the somata. Herpes simplex virus travels both ways in axons depending on its life cycle, with retrograde transport dominating polarity for incoming capsids.
Consequences of interruption
Whenever axonal transport is inhibited or interrupted, normal physiology becomes pathophysiology, and an accumulation of axoplasm, called an axonal spheroid, may result. Because axonal transport can be disrupted in a multitude of ways, axonal spheroids can be seen in many different classes of diseases, including genetic, traumatic, ischemic, infectious, toxic, degenerative and specific white matter diseases called leukoencephalopathies. Several rare neurodegenerative diseases are linked to genetic mutations in the motor proteins, kinesin and dynein, and in those cases it is likely that axonal transport is a key player in mediating pathology. Dysfunctional axonal transport is also linked to sporadic (common) forms of neurodegenerative diseases such as Alzheimer's and Parkinson's. This is mainly due to numerous observations that large axonal accumulations are invariably seen in affected neurons, and that genes known to play a role in the familial forms of these diseases also have purported roles in normal axonal transport. However, there is little direct evidence for involvement of axonal transport in the latter diseases, and other mechanisms (such as direct synaptotoxicity) may be more relevant.
Arrest of axoplasmic flow at the edge of ischemic area in vascular retinopathies lead to swelling of nerve fibres with give rise to soft exudates or cotton-wool patches.
Since the axon depends on axoplasmic transport for vital proteins and materials, injury such as diffuse axonal injury that interrupts the transport will cause the distal axon to degenerate in a process called Wallerian degeneration. Cancer drugs that interfere with cancerous growth by altering microtubules (which are necessary for cell division) damage nerves because the microtubules are necessary for axonal transport.
The rabies virus reaches the central nervous system by retrograde axoplasmic flow. The tetanus neurotoxin is internalised at the neuromuscular junction through binding the nidogen proteins and is retrogradely transported towards the soma in signaling endosomes. Neurotropic viruses, such the herpesviruses, travel inside axons using cellular transport machinery, as has been shown in work by Elaine Bearer's group. Other infectious agents are also suspected of using axonal transport. Such infections are now thought to contribute to Alzheimer's disease and other neurodegenerative neurological disorders.
- Sabry J, O'Connor TP, Kirschner MW (June 1995). "Axonal transport of tubulin in Ti1 pioneer neurons in situ". Neuron. 14 (6): 1247–56. doi:10.1016/0896-6273(95)90271-6. PMID 7541635.
- Oztas E (2003). "Neuronal Tracing" (PDF). Neuroanatomy. 2: 2–5. Archived (PDF) from the original on 2005-10-25.
- Karp G, van der Geer P. Cell and molecular biology: concepts and experiments (4th ed.). John Wiley. p. 344. ISBN 978-0-471-46580-5.
- Bear MF, Connors BW, Paradso MA (2007). Neuroscience : exploring the brain (3rd ed.). Lippincott Williams & Wilkins. p. 41. ISBN 978-0-7817-6003-4.
- Giustetto M, Hegde AN, Si K, Casadio A, Inokuchi K, Pei W, Kandel ER, Schwartz JH (November 2003). "Axonal transport of eukaryotic translation elongation factor 1alpha mRNA couples transcription in the nucleus to long-term facilitation at the synapse". Proceedings of the National Academy of Sciences of the United States of America. 100 (23): 13680–5. doi:10.1073/pnas.1835674100. PMC 263873. PMID 14578450.
- Si K, Giustetto Si K, Giustetto M, Etkin A, Hsu R, Janisiewicz AM, Miniaci MC, Kim JH, Zhu H, Kandel ER (December 2003). "A neuronal isoform of CPEB regulates local protein synthesis and stabilizes synapse-specific long-term facilitation in aplysia". Cell. 115 (7): 893–904. doi:10.1016/s0092-8674(03)01021-3. PMID 14697206.
- Roy S, Zhang B, Lee VM, Trojanowski JQ (January 2005). "Axonal transport defects: a common theme in neurodegenerative diseases". Acta Neuropathologica. 109 (1): 5–13. doi:10.1007/s00401-004-0952-x. PMID 15645263.
- Brown A (March 2003). "Axonal transport of membranous and nonmembranous cargoes: a unified perspective". The Journal of Cell Biology. 160 (6): 817–21. doi:10.1083/jcb.200212017. PMC 2173776. PMID 12642609.
- Scott DA, Das U, Tang Y, Roy S (May 2011). "Mechanistic logic underlying the axonal transport of cytosolic proteins". Neuron. 70 (3): 441–54. doi:10.1016/j.neuron.2011.03.022. PMC 3096075. PMID 21555071.
- Roy S, Winton MJ, Black MM, Trojanowski JQ, Lee VM (March 2007). "Rapid and intermittent cotransport of slow component-b proteins". The Journal of Neuroscience. 27 (12): 3131–8. doi:10.1523/JNEUROSCI.4999-06.2007. PMID 17376974.
- Kuznetsov AV (2011). "Analytical solution of equations describing slow axonal transport based on the stop-and-go hypothesis". Central European Journal of Physics. 9 (3): 662–673. doi:10.2478/s11534-010-0066-0.
- Holland DJ, Miranda-Saksena M, Boadle RA, Armati P, Cunningham AL (October 1999). "Anterograde transport of herpes simplex virus proteins in axons of peripheral human fetal neurons: an immunoelectron microscopy study". Journal of Virology. 73 (10): 8503–11. PMC 112870. PMID 10482603.
- Satpute-Krishnan P, DeGiorgis JA, Conley MP, Jang M, Bearer EL (October 2006). "A peptide zipcode sufficient for anterograde transport within amyloid precursor protein". Proceedings of the National Academy of Sciences of the United States of America. 103 (44): 16532–7. doi:10.1073/pnas.0607527103. PMC 1621108. PMID 17062754.
- Seamster PE, Loewenberg M, Pascal J, Chauviere A, Gonzales A, Cristini V, Bearer EL (October 2012). "Quantitative measurements and modeling of cargo-motor interactions during fast transport in the living axon". Physical Biology. 9 (5): 055005. doi:10.1088/1478-3975/9/5/055005. PMC 3625656. PMID 23011729.
- Gallagher JJ, Zhang X, Ziomek GJ, Jacobs RE, Bearer EL (April 2012). "Deficits in axonal transport in hippocampal-based circuitry and the visual pathway in APP knock-out animals witnessed by manganese enhanced MRI". NeuroImage. 60 (3): 1856–66. doi:10.1016/j.neuroimage.2012.01.132. PMC 3328142. PMID 22500926.
- Bearer EL, Manifold-Wheeler BC, Medina CS, Gonzales AG, Chaves FL, Jacobs RE (October 2018). "Alterations of functional circuitry in aging brain and the impact of mutated APP expression". Neurobiology of Aging. 70: 276–290. doi:10.1016/j.neurobiolaging.2018.06.018. PMC 6159914. PMID 30055413.
- Gibbs KL, Kalmar B, Sleigh JN, Greensmith L, Schiavo G (January 2016). "In vivo imaging of axonal transport in murine motor and sensory neurons". Journal of Neuroscience Methods. 257: 26–33. doi:10.1016/j.jneumeth.2015.09.018. PMC 4666412. PMID 26424507.
- Sleigh J, Schiavo G (2016). "Older but not slower: aging does not alter axonal transport dynamics of signalling endosomes in vivo". Matters. 2 (6). doi:10.19185/matters.201605000018.
- Cui B, Wu C, Chen L, Ramirez A, Bearer EL, Li WP, Mobley WC, Chu S (August 2007). "One at a time, live tracking of NGF axonal transport using quantum dots". Proceedings of the National Academy of Sciences of the United States of America. 104 (34): 13666–71. doi:10.1073/pnas.0706192104. PMC 1959439. PMID 17698956.
- Saladin, Kenneth. Anatomy and Physiology: The Unity of Form and Function. Sixth. New York : McGraw-Hill, 2010. 445. Print.
- Bearer EL, Breakefield XO, Schuback D, Reese TS, LaVail JH (July 2000). "Retrograde axonal transport of herpes simplex virus: evidence for a single mechanism and a role for tegument". Proceedings of the National Academy of Sciences of the United States of America. 97 (14): 8146–50. doi:10.1073/pnas.97.14.8146. PMC 16684. PMID 10884436.
- Maday S, Twelvetrees AE, Moughamian AJ, Holzbaur EL (October 2014). "Axonal transport: cargo-specific mechanisms of motility and regulation". Neuron. 84 (2): 292–309. doi:10.1016/j.neuron.2014.10.019. PMC 4269290. PMID 25374356.
- Mitrabhakdi E, Shuangshoti S, Wannakrairot P, Lewis RA, Susuki K, Laothamatas J, Hemachudha T (November 2005). "Difference in neuropathogenetic mechanisms in human furious and paralytic rabies". Journal of the Neurological Sciences. 238 (1–2): 3–10. doi:10.1016/j.jns.2005.05.004. PMID 16226769.
- Bercsenyi K, Schmieg N, Bryson JB, Wallace M, Caccin P, Golding M, Zanotti G, Greensmith L, Nischt R, Schiavo G (November 2014). "Tetanus toxin entry. Nidogens are therapeutic targets for the prevention of tetanus" (PDF). Science. 346 (6213): 1118–23. doi:10.1126/science.1258138. PMID 25430769.
- Satpute-Krishnan P, DeGiorgis JA, Bearer EL (December 2003). "Fast anterograde transport of herpes simplex virus: role for the amyloid precursor protein of alzheimer's disease". Aging Cell. 2 (6): 305–18. doi:10.1046/j.1474-9728.2003.00069.x. PMC 3622731. PMID 14677633.
- Cheng SB, Ferland P, Webster P, Bearer EL (March 2011). "Herpes simplex virus dances with amyloid precursor protein while exiting the cell". PLOS ONE. 6 (3): e17966. doi:10.1371/journal.pone.0017966. PMC 3069030. PMID 21483850.
- Bearer EL, Satpute-Krishnan P (September 2002). "The role of the cytoskeleton in the life cycle of viruses and intracellular bacteria: tracks, motors, and polymerization machines". Current Drug Targets. Infectious Disorders. 2 (3): 247–64. doi:10.2174/1568005023342407. PMC 3616324. PMID 12462128.
- Itzhaki RF, Lathe R, Balin BJ, Ball MJ, Bearer EL, Braak H, et al. (2016). "Microbes and Alzheimer's Disease". Journal of Alzheimer's Disease. 51 (4): 979–84. doi:10.3233/JAD-160152. PMC 5457904. PMID 26967229.
- "No place like asphalt for these hardy microbes". New Scientist. 206 (2757): 15. 2010. doi:10.1016/s0262-4079(10)60991-8.